Low-dose naltrexone’s utility for non-cancer centralized pain conditions: a scoping review

BACKGROUND: At low doses, naltrexone (LDN) has been shown to modulate inflammation through the interruption of microglial cell activation within the central nervous system. One of the most likely contributors to centralized pain is changes in microglial cell processing. Therefore, it has been postul...

Descripción completa

Detalles Bibliográficos
Autores principales: Rupp, Adam, Young, Erin, Chadwick, Andrea L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Special Populations Section
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628981/
https://www.ncbi.nlm.nih.gov/pubmed/37302106
http://dx.doi.org/10.1093/pm/pnad074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628981/
https://www.ncbi.nlm.nih.gov/pubmed/37302106
http://dx.doi.org/10.1093/pm/pnad074

Ejemplares similares